Andra AP fonden Acquires 11,895 Shares of Astera Labs, Inc. $ALAB

Andra AP fonden raised its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 33.8% in the 1st quarter, HoldingsChannel.com reports. The fund owned 47,100 shares of the company’s stock after purchasing an additional 11,895 shares during the quarter. Andra AP fonden’s holdings in Astera Labs were worth $5,162,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Eurizon Capital SGR S.p.A. acquired a new position in shares of Astera Labs in the 4th quarter valued at $18,708,000. Nordea Investment Management AB acquired a new stake in Astera Labs during the 4th quarter worth $2,028,000. Swedbank AB lifted its holdings in Astera Labs by 76.8% during the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after acquiring an additional 33,940 shares in the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new position in Astera Labs during the fourth quarter worth about $499,000. Finally, Revere Asset Management Inc acquired a new position in Astera Labs in the fourth quarter valued at about $589,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. Rothschild & Co Redburn began coverage on Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target for the company. Royal Bank Of Canada lifted their price objective on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, May 6th. Barclays increased their target price on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday. UBS Group raised their target price on shares of Astera Labs from $205.00 to $400.00 and gave the stock a “neutral” rating in a report on Monday, June 29th. Finally, Needham & Company LLC lifted their price target on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $282.00.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $330.89 on Thursday. The company has a market cap of $56.72 billion, a PE ratio of 223.57, a PEG ratio of 3.70 and a beta of 3.66. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The stock has a 50-day simple moving average of $355.80 and a 200 day simple moving average of $224.15.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the previous year, the firm posted $0.33 earnings per share. The firm’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts predict that Astera Labs, Inc. will post 1.86 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Bethany Mayer sold 686 shares of the stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total transaction of $270,997.44. Following the completion of the transaction, the director directly owned 5,550 shares in the company, valued at $2,192,472. This represents a 11.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 8,491 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $458.38, for a total value of $3,892,104.58. Following the completion of the transaction, the director owned 286,863 shares of the company’s stock, valued at $131,492,261.94. The trade was a 2.87% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 1,676,845 shares of company stock worth $444,928,806. 10.40% of the stock is currently owned by company insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.